Concepedia
Statistics
Publications
6
Citations
441
H-Index
Active since
2010
Affiliations
University of Tübingen(Current)
Technische Universität Dresden
Massachusetts General Hospital
University of Duisburg-Essen
University of Stuttgart
Daniela Beck is an author at University of Tübingen specializing in pharmacology, oncology, and melanoma pharmacotherapy.
Publications per year
2010–2018
Targeting hyperactivation of the <scp>AKT</scp> survival pathway to overcome therapy resistance of melanoma brain metastases
Heike Niessner, Andrea Forschner, Bernhard Klumpp et al. · Cancer Medicine · 2012 · 152 citations · Full text
Medicine, Oncology, Pharmacology +17
Vemurafenib Potently Induces Endoplasmic Reticulum Stress–Mediated Apoptosis in BRAFV600E Melanoma Cells
Daniela Beck, Heike Niessner, Keiran S.M. Smalley et al. · Science Signaling · 2013 · 144 citations · Full text
Life Sciences, Oncology, Pharmacology +12
The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells
Heike Niessner, Daniela Beck, Tobias Sinnberg et al. · Journal of Investigative Dermatology · 2010 · 66 citations · Full text
Life Sciences, Oncology, Pharmacology +14
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma
Heike Niessner, Tobias Sinnberg, Corinna Kosnopfel et al. · Clinical Cancer Research · 2017 · 49 citations · Full text
Medicine, Oncology, Pharmacology +16
Combined activity of temozolomide and the <scp>mTOR</scp> inhibitor temsirolimus in metastatic melanoma involves DKK1
Heike Niessner, Corinna Kosnopfel, Tobias Sinnberg et al. · Experimental Dermatology · 2017 · 15 citations
1–5 of 6